GeneTx, Ultragenyx (RARE) Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to GeneTx, Ultragenyx (RARE) Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome

Ultragenyx Pharma (RARE) Misses Q1 EPS by 36c

May 6, 2020 5:54 PM EDT

Ultragenyx Pharma (NASDAQ: RARE) reported Q1 EPS of ($2.05), $0.36 worse than the analyst estimate of ($1.69). Revenue for the quarter came in at $36.31 million versus the consensus estimate of $36.58 million.

The global coronavirus pandemic has created unprecedented challenges for the world at... More